Elena Nikulina

Pacific Biosciences of California convenes industry leaders as HiFi sequencing nears clinical lab adoption

Pacific Biosciences of California convenes industry leaders as HiFi sequencing nears clinical lab adoption
HiFi sequencing set for clinical labs

Pacific Biosciences of California is drawing attention to key considerations for clinical laboratories as HiFi sequencing technology approaches broader adoption. The company is hosting a panel with industry leaders from Myriad Genetics, GeneDx, Radboudumc, Karolinska, and PacBio to share expertise on critical aspects such as validation processes, assay consolidation, and upscaling laboratory workflows.

The panel offers insights for laboratories evaluating the integration of HiFi sequencing into their operations, with a focus on operational transition and performance validation. The session aims to clarify challenges and best practices as the technology gains momentum in clinical genomic testing.

Pacific Biosciences of California recently launched an Ampli-Fi workflow to support HiFi sequencing with lower DNA input. The company also introduced a HiFi Starter Kit designed to streamline sequencing projects and improve sample preparation. These offerings target key operational steps for laboratories engaging with HiFi sequencing technology.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.